GSK to start production of Ebola vaccine as tests on humans begin
17th September 2014
Clinical safety trials begin in US next week, after approval from the FDA; volunteer testing in UK and Africa from September.
GlaxoSmithKline’s experimental Ebola vaccine could be tested on humans in the UK, US, the Gambia and Mali in the next few weeks, in a race to contain the deadly virus that has claimed more than 1,500 lives in west Africa.
Read more at source article: www.theguardian.com